SGLT2 Inhibitors Between Reno Protective Effects and Impact on Bone and Mineral Disease Among Lupus Nephritis Patients

Conditions:   SGLT2 INHIBITORS;   Lupus Nephritis;   BMD Interventions:   Drug: Dapagliflozin tablet;   Drug: placebo Sponsor:   Mansoura University Active, not recruiting

Source: ClinicalTrials.gov - January 30, 2023 Category: Research Source Type: clinical trials